Cord Blood America Inc. CBAI Archives - Page 2 of 4

WednesdayJun 13, 2007 6:12 am

Cord Blood America, Inc. (CBAI.OB) CEO Updates Shareholders on Latest Progress

Matthew Schissler, CEO of Cord Blood America, addressed the shareholders concerning the company's latest progress. He stated, “I am 100% confident in the ability of CBAI to continue to grow, thrive and be a leader in the stem cell storage industry. I am also extremely excited about the current and future prospects of the organization, and have never felt better about the direction of our Company.” Cord Blood is very pleased with its many accomplishments. They have lowered operational loss, increased revenues, and halved the basic and diluted loss per share. In the second quarter, the company announced record revenues of…

WednesdayJun 06, 2007 4:31 am

Cord Blood America, Inc. (CBAI.OB) Evaluates Alternative Ways to Unlock Value for its Subsidiaries

Cord Blood America announced today that it has signed a consulting agreement with Midtown Partners & Co., LLC to find ways to unlock value for its subsidiaries. Matthew Schissler, Cord Blood America Chairman and CEO, stated, “Management sees this opportunity as a significant step forward in Cord Blood America's overall business plan. Management has worked diligently to line up this milestone opportunity, which could entirely fund the parent Company's future growth." The Senior Vice President at Midtown Parners commented on Cord Blood as being valuable, but doesn’t have the same attention other companies have in the public markets. He commented,…

TuesdayMay 29, 2007 6:08 am

Cord Blood America Inc. (CBAI.OB) Salutes Study Validating Insulin Generation from Umbilical Cord Blood

Cord Blood America, Inc. (CBAI.OB), reports that researchers at the University of Texas Medical Branch at Galveston who announced, in Science Daily, that they have engineered adult stem cells from human umbilical cord blood to produce insulin. This fundamental discovery could help cure type I diabetes by allowing people to grow their own insulin-producing cells for a damaged or defective pancreas, the Texas researchers said. "Diabetes is a far more common affliction than cancer and leukemia, traditionally treated with stem cells," said Matthew Schissler, Cord Blood America CEO. "The progress with stem cells to treat Type I diabetes may logically grow our potential…

TuesdayMay 29, 2007 4:52 am

Cord Blood America, Inc. (CBAI.OB) Reports Cord Blood has been Successfully Engineered to Make Insulin

Respected researchers at the University of Texas Medical Branch announced that they have engineered adult stem cells from human umbilical cord blood to produce insulin. The Texan researchers stated that the breakthrough could help cure type 1 diabetes by enabling people to produce their own insulin-producing cells. The researchers chose umbilical cord blood for its rich source of fresh stem cells. Matthew Scissler, CEO of Cord Blood America, stated, “Diabetes is a far more common affliction than cancer and leukemia, traditionally treated with stem cells. The progress with stem cells to treat Type I diabetes may logically grow our potential customer…

FridayMay 25, 2007 7:25 am

Cord Blood America, Inc. (CBAI.OB) is Well-Established in a Rapidly Growing Industry

In 2003, only five percent of the women giving birth in the U.S. knew about preserving their children’s umbilical cord blood, and only two percent of these women took advantage of this life-saving procedure. By the next year, the number of stored cord blood grew by 75 and has been growing ever since. The important blood is saved to treat certain diseases such as heart disease, Parkinson’s disease, spinal cord injuries, sickle cell anemia, Multiple Sclerosis and other difficult diseases. Researchers believe that these stem cells can someday be turned into any tissue in the body, which could repair a…

TuesdayMay 22, 2007 4:10 am

1st Quarter Revenues Reach $1.7 Million at Cord Blood America, Inc. (CBAI.OB)

Cord Blood America, Inc. (CBAI.OB), reports that revenues for the first quarter ended March 31, 2007, totaled $1.698 million, a new record quarter for the Company and up 208 percent compared to revenues totaling $551,060 in the same quarter in 2006. The Company reported gross profit of $599,255 in the first quarter of 2007 compared to gross profit of $25,852 in the same period in 2006. "The robust growth for this quarter shows that the business model we have established is working well," said CEO Matthew Schissler. "We will continue to seek accretive acquisitions and growth that make sense but do…

TuesdayMay 22, 2007 3:29 am

Cord Blood America, Inc. (CBAI.OB) Announces a 2300% Increase in Gross Profits

Cord Blood America is very pleased to announce its large profits for the first quarter of this year. Revenues increased 208% from $551,060 in the first quarter of 2006 to $1.698 Million in the first quarter of 2007. Gross profits experienced an even larger increase from $25,852 in the first quarter of 2006 to $599,255 in the first quarter of 2007, totaling for a 2300% gain. While the company grew, they greatly lowered costs by decreasing fees to directors, and by making cuts in labor and marketing. Through the changes Cord Blood decreased their loss from operations 145%. Matthew Scissler,…

ThursdayMay 17, 2007 12:17 pm

Cord Blood America, Inc. (CBAI.OB) Chief Executive Interviewed Regarding Link Between Cord Blood Stem Cell Collection and Cancer Treatment

Cord Blood America, Inc. (CBAI.OB) reported that its CEO, Matthew Schissler appeared on the "Your Cancer Today(TM)" show discussing umbilical cord blood stem cell collection and its enormous impact on the treatment of certain cancers. The show is now available for viewing at the Internet web site at http://www.yourcancertoday.com. Let us hear your thoughts below:

ThursdayMay 17, 2007 4:24 am

Cord Blood America, Inc. (CBAI.OB) To Air on Global Television

The CEO of Cord Blood America, Matthew Schissler, will make an appearance on the "Your Cancer Today" show. Topics discussed will include umbilical cord blood stem cell collection and its enormous impact on the treatment of certain cancers. The show will be available on global TV and on-line at the television show’s website. "Your Cancer Today" purposes to inform viewers about the current research being done on cancer, and about the available treatments. The CEO stated that the progress being made on umbilical cord blood storage is clearly evident, because it is being discussed on such an important television show. He…

MondayMay 14, 2007 5:23 am

Cord Blood America, Inc. (CBAI.OB) Takes Strong Move to Ensure Financial Soundness by Retiring Debt Early

Cord Blood America, Inc. (CBAI.OB), reports that it has reached agreement to retire the debt to the Bergen Community Regional Blood Centers, Paramus, New Jersey, six months ahead of maturity. The original note was for 12 months, for a quarter of a million dollars plus interest. Cord Blood America made six payments and now has retired the debt using a combination of cash flow and money from a private investor. "This agreement frees up cash for Cord Blood America and is an important step in ensuring our financial soundness," said Matthew Schissler, CEO, Cord Blood America. "We intend to keep retiring…

Site Search

Company Search

Tag: Cord Blood America Inc. CBAI